Phenominer Database Results (25 results)

 

Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Method Notes Record ID Study ID
LEXF4/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 21 38.1 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70047 1280
LEXF7C/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 16 0.0 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70052 1280
LEXF10A/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 30 13.3 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70056 1280
LEXF7B/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 20 40.0 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70051 1280
LEXF8D/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 14 35.7 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70062 1280
LEXF8B/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 25 72.0 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70620 1280
LEXF3/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 26 26.9 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70046 1280
LEXF6A/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 26 26.9 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70049 1280
LEXF7A/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 25 12.0 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70050 1280
LEXF8A/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 17 70.6 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70053 1280
F344/DuCrlCrlj percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 29 0.0 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70060 1280
LEXF10B/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 21 0.0 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70057 1280
LEXF10C/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 21 23.8 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70058 1280
LE/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 26 84.6 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70061 1280
LEXF1A/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 26 7.7 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70040 1280
LEXF1B/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 26 0.0 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70041 1280
LEXF1C/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 23 4.3 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70042 1280
LEXF2A/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 21 71.4 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70043 1280
LEXF2B/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 20 5.0 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70044 1280
LEXF2D/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 19 78.9 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70621 1280
LEXF2C/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 20 10.0 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70045 1280
LEXF5/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 19 73.7 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70048 1280
LEXF8C/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 20 75.0 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70054 1280
LEXF9/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 27 77.8 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70055 1280
LEXF11/Stm percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40 days-365 days 25 0.0 % ex vivo light microscopy with immunohistochemistry 0.0 0 light microscopy with immuno 70059 1280